TP53 and breast carcinoma: We retrieved the data for manageably small subsets of breast cancer from cBioportal [https://www.cbioportal.org/], identified their mutant TP53 molecules, and evaluated their phylogenetic analysis with the matrix methods versus three conventional algorithms for their relationships to quantitative clinical readouts.